- Home
- ABBV vs ETN Comparison
ABBV vs ETN Comparison
Compare ABBV & ETN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | ETN |
|---|---|---|
| Founded | 2012 | 1916 |
| Country | United States | Ireland |
| Employees | N/A | 101000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 160.3B |
| IPO Year | 2012 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ABBV | ETN |
|---|---|---|
| Price | $251.75 | $403.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 22 |
| Target Price | $253.71 | ★ $401.95 |
| AVG Volume (30 Days) | ★ 4.1M | 2.3M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.39% | 1.07% |
| EPS Growth | N/A | ★ 10.00 |
| EPS | 0.39 | ★ 2.22 |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.87 | $12.72 |
| Revenue Next Year | $8.12 | $9.54 |
| P/E Ratio | $625.28 | ★ $188.85 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $181.75 | $311.92 |
| 52 Week High | $244.81 | $436.74 |
Technical Indicators
Market Signals| Indicator | ABBV | ETN |
|---|---|---|
| Relative Strength Index (RSI) | 75.20 | 48.41 |
| Support Level | $213.65 | $355.03 |
| Resistance Level | N/A | $408.45 |
| Average True Range (ATR) | 5.90 | 14.19 |
| MACD | 2.32 | 0.35 |
| Stochastic Oscillator | 99.62 | 42.19 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About ETN Eaton Corporation PLC
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.